Clindamycin Suspension Generics - Manufacturers & Suppliers
Cleocin, Clindamycin, Dalacin C(US); Dalacin C, Clindamycine(EU)
| Product/Composition:- | Clindamycin Suspension |
|---|---|
| Strength:- | 75 mg/5 mL, 150 mg/5 mL, 300 mg/5 mL |
| Form:- | Suspension |
| Reference Brands:- | Cleocin, Clindamycin, Dalacin C(US); Dalacin C, Clindamycine(EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Clindamycin suspension inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking peptide chain formation. It effectively treats pediatric and adult bacterial infections, including respiratory and skin infections. Benefits include ease of oral administration, rapid bacterial eradication, excellent tissue penetration, and a favorable safety profile when used correctly.
Clindamycin suspension is approved in the EU and US for pediatric and adult bacterial infections, including respiratory and skin infections. In the EU, brands like Cleocin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We enable seamless market access for clindamycin suspension, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.